FundedIQ
Biotechnology

Pasithea Therapeutics: Funding, Investors & Team (Oct 2026)

Pasithea Therapeutics is a biotechnology organization that looks to tackle clinical issues like emotional wellness. The organization is driven by famous immunologists based at Stanford University and their scholarly exploration is going by a top mental scholastic at King's College London. The drawn out point is to make an interpretation of examination into center prepared drugs. Pasithea Therapeutics' auxiliary tasks center around laying out enemy of misery facilities and portable centers across the US and UK, utilizing prepared drug specialists to direct intravenous imbuements of ketamine. Pasithea has cooperated with two effective facilities (THE IV DOC and Zen Health) for guaranteed openness in areas across Los Angeles, New York City, and London.

pasitheaclinics.com LinkedIn Venice, United States 1-10 employees
Total raised
$5.7M
Rounds
2
Latest
Undisclosed round
Sep 2024

Pasithea Therapeutics has raised $5.7M across 2 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Sep 2024.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Pasithea Therapeutics Company Profile and Key Stats

Total funding raised
$5.7M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$5.0M in Sep 2024
Employees
1-10
reported band
Headquarters
Venice, United States

Latest funding round on record: Sep 2024.

Pasithea Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
$5.0M
Grant
$680k

Pasithea Therapeutics raised $680k in a Grant announced in Jul 2022.

2.2 years later, an undisclosed round of $5.0M was announced in Sep 2024.

Pasithea Therapeutics Founders and Leadership Team

Name
Role
Contact
Tiago Reis Marques
Founder
—

No contact details are on record for this team yet.

Pasithea Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Pasithea Therapeutics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Pasithea Therapeutics in Biotechnology and Venice

Companies Similar to Pasithea Therapeutics

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Pasithea Therapeutics Funding FAQs

What does Pasithea Therapeutics do?

Pasithea Therapeutics is a biotechnology organization that looks to tackle clinical issues like emotional wellness. The organization is driven by famous immunologists based at Stanford University and their scholarly exploration is going by a top mental scholastic at King's College London. The drawn out point is to make an interpretation of examination into center prepared drugs. Pasithea Therapeutics' auxiliary tasks center around laying out enemy of misery facilities and portable centers across the US and UK, utilizing prepared drug specialists to direct intravenous imbuements of ketamine. Pasithea has cooperated with two effective facilities (THE IV DOC and Zen Health) for guaranteed openness in areas across Los Angeles, New York City, and London.

How much funding has Pasithea Therapeutics raised?

Pasithea Therapeutics has raised $5.7M across 2 rounds on record. The most recent is an undisclosed round of $5.0M announced in Sep 2024.

When did Pasithea Therapeutics last raise funding?

Pasithea Therapeutics' most recent funding round on record is an undisclosed round of $5.0M, announced in Sep 2024.

Who founded Pasithea Therapeutics?

FundedIQ lists Tiago Reis Marques (Founder) at Pasithea Therapeutics.

Where is Pasithea Therapeutics headquartered?

Pasithea Therapeutics is based in Venice, California, United States.

How many employees does Pasithea Therapeutics have?

Pasithea Therapeutics is in the 1-10 employee band.

How does Pasithea Therapeutics' funding compare to other Biotechnology startups?

Pasithea Therapeutics' latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Pasithea Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pasithea Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.